Mazen Noureddin
机构：Cedars-Sinai Medical Center, Houston Methodist, Methodist Hospital, Pinnacle Clinical Research, Houston Institute for Clinical Research, Karshi State University · ORCID：0000-0003-2127-2040
发表论文 541 篇 · 总被引 22502 次 · h-index 75
代表论文
- Effects of Resmetirom on Metabolic‐Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon‐Like Peptide‐1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO ‐ NASH Trial (2025 · Alimentary Pharmacology & Therapeutics · 被引 20)
- Development of AI Based Fibrosis Detection Algorithm by SHG / TPEF Microscopy for Fully Quantified Liver Fibrosis Assessment in MASH (2025 · Liver International · 被引 11)
- Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-Analysis (2025 · Clinical Gastroenterology and Hepatology · 被引 7)
- Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-Associated Steatohepatitis (2025 · Clinical Gastroenterology and Hepatology · 被引 6)
- Waitlist and Post‐Transplant Outcomes in Liver Transplantation for Alcohol‐Associated Liver Disease: An Individual Patient Data Meta‐Analysis (2025 · Alimentary Pharmacology & Therapeutics · 被引 4)
- Comparative efficacy of phase 2–3 therapies for non-cirrhotic metabolic dysfunction-associated steatohepatitis: An updated network meta-analysis (2026 · Med · 被引 1)